Lyn D. Ferguson

Glasgow, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 35 publications

GRAPPA 2025 Annual Meeting: Advances in Psoriatic Disease Research From Pilot Grant Awardees.

GRAPPA 2025 Annual Meeting: Advances in Psoriatic Disease Research From Pilot Grant Awardees.

Journal: The Journal of rheumatology

Published: April 13, 2026

From adiposity to multisystem morbidity: the case for weight loss as disease modification.

From adiposity to multisystem morbidity: the case for weight loss as disease modification.

Journal: The lancet. Diabetes & endocrinology

Published: March 06, 2026

Beyond the scales: time to prioritise treatment of obesity in psoriatic disease.

Beyond the scales: time to prioritise treatment of obesity in psoriatic disease.

Journal: Annals of the rheumatic diseases

Published: November 12, 2025

Cytokine pathways driving diverse tissue pathologies in rheumatoid arthritis.

Cytokine pathways driving diverse tissue pathologies in rheumatoid arthritis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: March 26, 2025

Weighing in on obesity and psoriatic arthritis - Time to move beyond association to robust randomised trials.

Weighing in on obesity and psoriatic arthritis - Time to move beyond association to robust randomised trials.

Journal: Joint bone spine

Published: March 18, 2025

WITHDRAWN: Weighing in on obesity and psoriatic arthritis - Time to move beyond association to robust randomised trials.

WITHDRAWN: Weighing in on obesity and psoriatic arthritis - Time to move beyond association to robust randomised trials.

Journal: Joint bone spine

Published: January 11, 2025

Obesity substantially impacts rheumatic and musculoskeletal diseases: time to act.

Obesity substantially impacts rheumatic and musculoskeletal diseases: time to act.

Journal: Annals of the rheumatic diseases

Published: November 25, 2024

In which common chronic conditions can (or cannot) obesity and lifestyle factors explain higher concentrations of C-reactive protein?

In which common chronic conditions can (or cannot) obesity and lifestyle factors explain higher concentrations of C-reactive protein?

Journal: Diabetes, obesity & metabolism

Published: June 23, 2024

Association of a dietary inflammatory index with cardiometabolic, endocrine, liver, renal and bones biomarkers: cross-sectional analysis of the UK Biobank study.

Association of a dietary inflammatory index with cardiometabolic, endocrine, liver, renal and bones biomarkers: cross-sectional analysis of the UK Biobank study.

Journal: Nutrition, metabolism, and cardiovascular diseases : NMCD

Published: November 08, 2023

Gout and incidence of 12 cardiovascular diseases: a case-control study including 152 663 individuals with gout and 709 981 matched controls.

Gout and incidence of 12 cardiovascular diseases: a case-control study including 152 663 individuals with gout and 709 981 matched controls.

Journal: The Lancet. Rheumatology

Published: September 12, 2023

Managing Cardiovascular Risk in Patients with Rheumatic Disease.

Managing Cardiovascular Risk in Patients with Rheumatic Disease.

Journal: Rheumatic diseases clinics of North America

Published: April 11, 2022

Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes: A prospective cohort study in the UK Biobank.

Association of gamma-glutamyltransferase levels with total mortality, liver-related and cardiovascular outcomes: A prospective cohort study in the UK Biobank.

Journal: EClinicalMedicine

Published: December 14, 2021

Showing 1-12 of 35

Last Updated: 09/26/2026